WINNIPEG, MANITOBA -- (MARKET WIRE) -- April 24, 2007 -- Miraculins Inc. (TSX VENTURE: MOM), a biotechnology company engaged in the discovery and development of biomarkers and diagnostics for select cancers, is pleased to announce that the Company will be providing a corporate update at BioFinance 2007 in Toronto.
